Lite Strategy, Inc. — Director's Dealing 2018

Jul 16, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MEI Pharma, Inc. (MEIP)
CIK: 0001262104
Period of Report: 2018-07-12

Reporting Person: Reynolds Thomas C (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-07-12	Stock Option (Right to Buy)	$4.28	A	40000	Acquired	2028-07-12	Common Stock (40000)	Direct

Footnotes

F1: The options will vest in equal monthly installments over twelve months.